Clinical commercialization for technologies that improve outcomes and reduce cost.
Great health technology doesn't fail because it doesn't work. It fails because it doesn't get adopted. We fix that.
Getting into health systems takes more than a good product. It takes relationships, evidence, and someone who knows how adoption actually works on the inside.
Your innovation teams build breakthrough technology, but internal conflicts of interest and limited commercial infrastructure make it nearly impossible to bring to market from the inside. We handle that.
Not theoretically. Measurably. If you can't prove the improvement with data, it doesn't go in the bag.
If the technology doesn't save the health system money at scale, it doesn't belong in our portfolio.
Great technology dies between the purchase order and the practice change. If clinicians won't use it, we won't carry it.
Does it improve outcomes, reduce cost, and fit into clinical workflow? All three must be yes before we engage.
Positioning, pricing, target health systems, and the evidence strategy needed to get in the door.
We introduce your technology to the right people at the right institutions. Not a target list. Actual introductions.
We design and run structured clinical pilots. Real data from real patients at real institutions.
The deal isn't done when the PO is signed. It's done when clinicians are using it every day.
Evidence from Hospital A sells Hospital B. Each implementation builds the case. Adoption accelerates.
Through our partnership with Nova Rain Capital, you get more than funding — you get a global strategic platform. Capital, U.S. commercialization infrastructure, and access to emerging markets, licensing structures, and partnerships that drive long-term value creation. One relationship, full pathway.
Learn more about the partnership →